North America
The Forerunner Ventures-led investment brings Modern Fertility's total backing to $22 million.
The company's platform helps patients navigate care following testing, while also offering virtual expert consultations to doctors.
The announcement is yet another milestone on the road to adoption and reimbursement of digital therapies, Big Health CEO Peter Hames said.
The startup will use the new funds to scale its at-home care model to more customers.
The Hamilton and Amabel James Center for Artificial Intelligence and Human Health will focus on genomics, modeling and prediction of novel therapies and enhanced imaging.
Khosla Ventures led the funding round with participation from Dai-ichi Life, SOMPO holdings, Sozo Ventures, Rethink Impact, AME Cloud Partners and Marc Benioff.
The IB-Stim device adheres behind the patient's ear for up to five days, and may assist with pain reduction for up to three consecutive weeks.
The FDA approval closes a gap with competitors Dexcom and Abbott, as well as setting the company up for entry into the Medicare market.
The sector has undergone major changes in the past few years, and venture capitalists are still keen to dip their toes in.